AEterna Zentaris Inc.

(AEZS) Trade

By |

Profile

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3201
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: USA
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Michael Ward
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.

Contact Information

Website: www.zentaris.com
Email: ir@aezsinc.com
Main Phone: +1 843 900-3201
Address: 315 Sigma Drive
Address 2: Suite 302D
State: SC
City / Town: Summerville
Country: USA
Postal Code: 29486

Issuer Information

Exchange: NSC
CEO: Michael Ward
Employees: 22
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.02 $ 0.27 (9.82%)
Last Price 3.02 Change $ 0.27 Change % 9.82 Tick N/A
Bid 3.00 Bid Size 100.00 Ask 3.46 Ask Size 500.00
Open 2.79 High 3.11 Low 2.73 Prev Close 2.75
Last Trade Volume 357,153 52 Wk Hi 5.57 52 Wk Low 1.29
Market Cap 49 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 16,210,267.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 3 3 3 3
Mean Target Price Estimate 3.5 3.5 3.5 3.5
Standard Deviation 0.71 0.71 0.71 0.71
Date of Most Recent Estimate 04/05/18 04/05/18 04/05/18 04/05/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1